Forced inspiratory volume in one second (FIV1 ) in the assessment of reversibility of airway obstruction in patients with chronic obstructive pulmonary disease (COPD) and in relation to the severity Source: Eur Respir J 2002; 20: Suppl. 38, 300s Year: 2002
Treatment with corticosteroids and yearly decline of forced expiratory flow (FEV1 ) in patients with severe chronic obstructive pulmonary disease (COPD) Source: Annual Congress 2008 - Respiratory structure and function Year: 2008
The relationship between peak expiratory flow rate (PEFR) and forced expiratroy volume in the first second (FEV1) at low levels of FEV1. Implications for the assessment of COPD (chronic obstructive pulmonary disease) in primary care Source: Eur Respir J 2002; 20: Suppl. 38, 397s Year: 2002
Does the decrease in KCO go typically with DLCO decrease in obstructive pulmonary diseases? The relationship with DLCO, KCO, VA and VA/TLC in patients with COPD> Source: International Congress 2018 – Functional assessment of COPD Year: 2018
Forced expiratory volume in one second (FEV1 ) and peak expiratory flow (PEF): is there a correlation in chronic obstructive pulmonary disease (COPD) patients? Source: Eur Respir J 2001; 18: Suppl. 33, 213s Year: 2001
FEV6 or FVC to detect airway obstruction in the community setting? Source: Annual Congress 2007 - PG17 - Lung function measurement in the community Year: 2007
Obstructive and restrictive spirometric patterns: fixed cut-offs for FEV1/FEV6 and FEV6 Source: Eur Respir J 2006; 27: 378-383 Year: 2006
Post-bronchodilator response (PBDR) evaluated by plethysmographic and spirometric target parameters in patients with COPD, asthma-COPD-overlap (ACO) and asthma Source: International Congress 2018 – Innovations in equipment and their application Year: 2018
Comparison between presence of respiratory symptoms and peak expiratory flow (PEF) values <80% predicted as screening tools for obstructive airways diseases (OAD) Source: Annual Congress 2011 - Monitoring with lung function tests in airway diseases Year: 2011
Population surveillance in North West Adelaide: lung function and chronic obstructive pulmonary disease (COPD) across the diabetes spectrum Source: Annual Congress 2005 - Assessing the relevance of obstructive airway diseases Year: 2005
Comparison of spirometric z-scores with FEV1 percent prediction in predicting exacerbations in elderly COPD patients Source: International Congress 2016 – In-patient and out-patient COPD management Year: 2016
Six minute walk distance (6MWD) and pulmonary diffusing capacity (DLCO) in patients with COPD Source: International Congress 2015 – COPD: notable points Year: 2015
The relationship between COPD assessment test (CAT) scores and severity of airflow obstruction in stable COPD patients Source: Annual Congress 2012 - Quality of life and clinical parametres in monitoring airway diseases Year: 2012
Hoover‘s sign predicts expiratory flow limitation in chronic obstructive pulmonary disease (COPD) Source: Eur Respir J 2006; 28: Suppl. 50, 807s Year: 2006
The body-mass index, airflow obstruction, dyspnea, and exercise capacity (BODE) index in Filipino patients with chronic obstructive pulmonary disease (COPD) Source: Eur Respir J 2005; 26: Suppl. 49, 57s Year: 2005
Osteoprotogerin plasma concentrations is correlate with forced expiratory volume at 1 second (FEV1) in patients with COPD Source: Annual Congress 2013 –Systemic and airway biomarkers in respiratory diseases Year: 2013
Relationship of airway dimensions with airflow limitation or lung volumes in chronic obstructive pulmonary disease (COPD) Source: Eur Respir Rev 2006; 15: 197-199 Year: 2006
Post-bronchodilator FVC determines pulmonary rehabilitation outcomes in patients with chronic obstructive pulmonary disease Source: Annual Congress 2011 - Challenges in rehabilitation: some old dilemmas revisited with some solutions? Year: 2011
Individual relationship between weather variables and lung function in patients with chronic obstructive pulmonary disease (COPD) Source: Eur Respir J 2005; 26: Suppl. 49, 385s Year: 2005
Comparison of pre and post-bronchodilator single-breath and re-breathe DLCO values amongst healthy, asthmatic and COPD subjects Source: Annual Congress 2013 –New issues in lung function testing Year: 2013